carbon tetrachloride has been researched along with Lung Neoplasms in 9 studies
Carbon Tetrachloride: A solvent for oils, fats, lacquers, varnishes, rubber waxes, and resins, and a starting material in the manufacturing of organic compounds. Poisoning by inhalation, ingestion or skin absorption is possible and may be fatal. (Merck Index, 11th ed)
tetrachloromethane : A chlorocarbon that is methane in which all the hydrogens have been replaced by chloro groups.
Lung Neoplasms: Tumors or cancer of the LUNG.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the role of monomethyltriazenes as the active metabolites of antitumor dimethyltriazenes, the in vivo simultaneous treatment with an inducer (phenobarbital, PB) or an inhibitor (carbon tetrachloride, CCl4) of hepatic drug metabolism was examined in mice bearing Lewis lung carcinoma." | 3.67 | Effects of an inducer and an inhibitor of hepatic metabolism on the antitumor action of dimethyltriazenes. ( Giraldi, T; Lassiani, L; Perissin, L; Sava, G; Zorzet, S, 1988) |
| " No other chlorinated solvents showed both statistically significant associations and dose-response relationships." | 2.49 | Risk of lung cancer associated with six types of chlorinated solvents: results from two case-control studies in Montreal, Canada. ( Christensen, KY; Lavoué, J; Siemiatycki, J; Vizcaya, D, 2013) |
| "One of 18 animals developed a hepatoma, but none of the mice given CCl4 in 0." | 1.25 | Preparative action of carbon tetrachloride in liver tumorigenesis by a single application of N-butylnitrosourea in male ICR/JCL strain mice. ( Inoue, S; Naito, Y; Takizawa, S; Watanabe, H, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (55.56) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Amor, C | 1 |
| Feucht, J | 1 |
| Leibold, J | 1 |
| Ho, YJ | 1 |
| Zhu, C | 1 |
| Alonso-Curbelo, D | 1 |
| Mansilla-Soto, J | 1 |
| Boyer, JA | 1 |
| Li, X | 1 |
| Giavridis, T | 1 |
| Kulick, A | 1 |
| Houlihan, S | 1 |
| Peerschke, E | 1 |
| Friedman, SL | 1 |
| Ponomarev, V | 1 |
| Piersigilli, A | 1 |
| Sadelain, M | 1 |
| Lowe, SW | 1 |
| Leeming, Dj | 1 |
| He, Y | 1 |
| Veidal, S | 1 |
| Nguyen, Q | 1 |
| Larsen, D | 1 |
| Koizumi, M | 1 |
| Segovia-Silvestre, T | 1 |
| Zhang, C | 1 |
| Zheng, Q | 1 |
| Sun, S | 1 |
| Cao, Y | 1 |
| Barkholt, V | 1 |
| Hägglund, P | 1 |
| Bay-Jensen, A | 1 |
| Qvist, P | 1 |
| Karsdal, M | 1 |
| Vizcaya, D | 1 |
| Christensen, KY | 1 |
| Lavoué, J | 1 |
| Siemiatycki, J | 1 |
| Alley, MC | 1 |
| Powis, G | 1 |
| Appel, PL | 1 |
| Kooistra, KL | 1 |
| Lieber, MM | 1 |
| Sawada, S | 1 |
| Murakami, K | 1 |
| Murata, J | 1 |
| Tsukada, K | 1 |
| Saiki, I | 1 |
| Reuber, MD | 1 |
| Glover, EL | 1 |
| Takizawa, S | 1 |
| Watanabe, H | 1 |
| Naito, Y | 1 |
| Inoue, S | 1 |
| Sava, G | 1 |
| Zorzet, S | 1 |
| Perissin, L | 1 |
| Giraldi, T | 1 |
| Lassiani, L | 1 |
| Dzhioev, FK | 1 |
| Balanski, RM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Pilot Study of Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients[NCT05637216] | Phase 2 | 40 participants (Anticipated) | Interventional | 2023-08-17 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for carbon tetrachloride and Lung Neoplasms
| Article | Year |
|---|---|
Risk of lung cancer associated with six types of chlorinated solvents: results from two case-control studies in Montreal, Canada.
Topics: Adult; Aged; Carbon Tetrachloride; Case-Control Studies; Female; Humans; Hydrocarbons, Chlorinated; | 2013 |
8 other studies available for carbon tetrachloride and Lung Neoplasms
| Article | Year |
|---|---|
Senolytic CAR T cells reverse senescence-associated pathologies.
Topics: Adenocarcinoma; Aging; Animals; Carbon Tetrachloride; Cellular Senescence; Female; Heterografts; Hum | 2020 |
A novel marker for assessment of liver matrix remodeling: an enzyme-linked immunosorbent assay (ELISA) detecting a MMP generated type I collagen neo-epitope (C1M).
Topics: Animals; Bile Ducts; Biomarkers; Bone Neoplasms; Breast Neoplasms; Carbon Tetrachloride; Collagen Ty | 2011 |
Activation and inactivation of cancer chemotherapeutic agents by rat hepatocytes cocultured with human tumor cell lines.
Topics: Animals; Antineoplastic Agents; Carbon Tetrachloride; Cell Survival; Colony-Forming Units Assay; Cyc | 1984 |
Accumulation of extracellular matrix in the liver induces high metastatic potential of hepatocellular carcinoma to the lung.
Topics: Animals; Carbon Tetrachloride; Carcinoma, Hepatocellular; DNA Primers; Extracellular Matrix; Extrace | 2001 |
Cirrhosis and carcinoma of the liver in male rats given subcutaneous carbon tetrachloride.
Topics: Animals; Carbon Tetrachloride; Carcinogens; Injections, Subcutaneous; Liver Cirrhosis; Liver Neoplas | 1970 |
Preparative action of carbon tetrachloride in liver tumorigenesis by a single application of N-butylnitrosourea in male ICR/JCL strain mice.
Topics: Age Factors; Animals; Carbon Tetrachloride; Carcinogens; Carcinoma, Hepatocellular; Drug Synergism; | 1975 |
Effects of an inducer and an inhibitor of hepatic metabolism on the antitumor action of dimethyltriazenes.
Topics: Animals; Antineoplastic Agents; Biotransformation; Carbon Tetrachloride; Carcinoma; Liver; Lung Neop | 1988 |
[Inhibition of urethane carcinogenesis by antioxidants and carbon tetrachloride].
Topics: Adenoma; Administration, Oral; Animals; Antioxidants; Carbon Tetrachloride; Cell Transformation, Neo | 1974 |